Intratumor heterogeneity in epithelial cancer: Assessment in cell line models and circulating tumor cells

Background: CTCs are present only in small numbers in patients' blood. This study aimed to establish a protocol for enumeration and phenotypic characterization of circulating tumor cells (CTCs) by ImageStreamX MK II (AMNIS) imaging flow cytometry and to characterize the expression of epithelial...

Full description

Bibliographic Details
Main Authors: Wimba W. Dinutanayo, Ingeborg T. Keilholz, Diana Braunholz
Format: Article
Language:English
Published: Universitas Indonesia 2019-04-01
Series:Makara Journal of Health Research
Subjects:
Online Access:https://scholarhub.ui.ac.id/mjhr/vol23/iss1/9/
_version_ 1797893821988601856
author Wimba W. Dinutanayo
Ingeborg T. Keilholz
Diana Braunholz
author_facet Wimba W. Dinutanayo
Ingeborg T. Keilholz
Diana Braunholz
author_sort Wimba W. Dinutanayo
collection DOAJ
description Background: CTCs are present only in small numbers in patients' blood. This study aimed to establish a protocol for enumeration and phenotypic characterization of circulating tumor cells (CTCs) by ImageStreamX MK II (AMNIS) imaging flow cytometry and to characterize the expression of epithelial, mesenchymal, and stem cell markers in CTCs. Methods: The study used the FaDu cell line at different passages, cisplatin-resistant (FaDu CDDP-R), and irradiation-resistant (FaDu IR-R) subclones, as well as blood samples from head and neck squamous cell carcinoma (HNSCC) and colorectal cancer (CRC) patients for CTC detection (n = 5). Cells were fixed using 4% paraformaldehyde and permeabilized by incubation in 0.3% Triton X-100. The cell suspensions were stained with 1:100 EpCAM AF-488, 1:50 CD45 AF-647, 1:50 Vimentin AF-555, and 1:50 ALDH1A AF-594 antibodies. Results: There were significant differences in EpCAM expression levels between FaDu at late passage and FaDu CDDP-R subclones, as well as between FaDu at late passage compared with FaDu IR-R. Furthermore, CTCs were successfully detected in five patients' samples with various CTC subpopulations. Conclusions: Intratumor heterogeneity in CTC phenotypes existed in CRC and HNSCC. Furthermore, three main subpopulations of CTCs were detected. Our findings strongly support future phenotypic studies of CTCs.
first_indexed 2024-04-10T06:59:11Z
format Article
id doaj.art-1b3b2fcf84a34a33b585517bdc82f2e2
institution Directory Open Access Journal
issn 2356-3664
2356-3656
language English
last_indexed 2024-04-10T06:59:11Z
publishDate 2019-04-01
publisher Universitas Indonesia
record_format Article
series Makara Journal of Health Research
spelling doaj.art-1b3b2fcf84a34a33b585517bdc82f2e22023-02-28T02:41:28ZengUniversitas IndonesiaMakara Journal of Health Research2356-36642356-36562019-04-01231536310.7454/msk.v23i1.10149Intratumor heterogeneity in epithelial cancer: Assessment in cell line models and circulating tumor cellsWimba W. Dinutanayo0Ingeborg T. Keilholz1Diana Braunholz2Faculty of Health, Medicine, and Life Science, Maastricht University, the NetherlandsTranslational Radiation Oncology Research Laboratory, Department of Radiation Oncology and Radiotherapy, Charité Universitätsmedizin Berlin, GermanyTranslational Radiation Oncology Research Laboratory, Department of Radiation Oncology and Radiotherapy, Charité Universitätsmedizin Berlin, GermanyBackground: CTCs are present only in small numbers in patients' blood. This study aimed to establish a protocol for enumeration and phenotypic characterization of circulating tumor cells (CTCs) by ImageStreamX MK II (AMNIS) imaging flow cytometry and to characterize the expression of epithelial, mesenchymal, and stem cell markers in CTCs. Methods: The study used the FaDu cell line at different passages, cisplatin-resistant (FaDu CDDP-R), and irradiation-resistant (FaDu IR-R) subclones, as well as blood samples from head and neck squamous cell carcinoma (HNSCC) and colorectal cancer (CRC) patients for CTC detection (n = 5). Cells were fixed using 4% paraformaldehyde and permeabilized by incubation in 0.3% Triton X-100. The cell suspensions were stained with 1:100 EpCAM AF-488, 1:50 CD45 AF-647, 1:50 Vimentin AF-555, and 1:50 ALDH1A AF-594 antibodies. Results: There were significant differences in EpCAM expression levels between FaDu at late passage and FaDu CDDP-R subclones, as well as between FaDu at late passage compared with FaDu IR-R. Furthermore, CTCs were successfully detected in five patients' samples with various CTC subpopulations. Conclusions: Intratumor heterogeneity in CTC phenotypes existed in CRC and HNSCC. Furthermore, three main subpopulations of CTCs were detected. Our findings strongly support future phenotypic studies of CTCs.https://scholarhub.ui.ac.id/mjhr/vol23/iss1/9/cancer stem cellcirculating tumor cellepithelial-mesenchymal transitionimaging flow cytometryliquid biopsyneoplastic cells
spellingShingle Wimba W. Dinutanayo
Ingeborg T. Keilholz
Diana Braunholz
Intratumor heterogeneity in epithelial cancer: Assessment in cell line models and circulating tumor cells
Makara Journal of Health Research
cancer stem cell
circulating tumor cell
epithelial-mesenchymal transition
imaging flow cytometry
liquid biopsy
neoplastic cells
title Intratumor heterogeneity in epithelial cancer: Assessment in cell line models and circulating tumor cells
title_full Intratumor heterogeneity in epithelial cancer: Assessment in cell line models and circulating tumor cells
title_fullStr Intratumor heterogeneity in epithelial cancer: Assessment in cell line models and circulating tumor cells
title_full_unstemmed Intratumor heterogeneity in epithelial cancer: Assessment in cell line models and circulating tumor cells
title_short Intratumor heterogeneity in epithelial cancer: Assessment in cell line models and circulating tumor cells
title_sort intratumor heterogeneity in epithelial cancer assessment in cell line models and circulating tumor cells
topic cancer stem cell
circulating tumor cell
epithelial-mesenchymal transition
imaging flow cytometry
liquid biopsy
neoplastic cells
url https://scholarhub.ui.ac.id/mjhr/vol23/iss1/9/
work_keys_str_mv AT wimbawdinutanayo intratumorheterogeneityinepithelialcancerassessmentincelllinemodelsandcirculatingtumorcells
AT ingeborgtkeilholz intratumorheterogeneityinepithelialcancerassessmentincelllinemodelsandcirculatingtumorcells
AT dianabraunholz intratumorheterogeneityinepithelialcancerassessmentincelllinemodelsandcirculatingtumorcells